Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Therapies Selection Study for Metastatic Colorectal Carcinoma
NCT01703910Phase 2Completed
- Sponsor
- Spanish National Cancer Research Centre
- Start
- Nov 2012
- Primary completion
- Nov 2012
- Modality
- Fragment-Derived Small Molecules, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, cisplatin, cetuximab, doxorubicin, fluorouracil in colorectal carcinoma (CRC), sponsored by Spanish National Cancer Research Centre. Started Nov 2012; status: completed.
02
Drugs
capecitabinecisplatincetuximabdoxorubicinfluorouracil
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT01703910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01703910.